Did an Alzheimer's drug give Sue and Ken Bell more time? Maybe.
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.
(Image credit: Michael B. Thomas/NPR)
